0 evaluări0% au considerat acest document util (0 voturi)
2 vizualizări2 pagini
The document provides a reference list of 30 sources on topics related to breast cancer pathology and classification. The references cover journal articles, books, websites, and other literature. They address issues such as the WHO classification of breast tumors, ductal carcinoma in situ, hormone receptor status, HER2 testing, squamous cell carcinoma of the breast, and methodologies for clinical research. The list cites international pathology and oncology publications from multiple decades ranging from the early 1990s to 2009.
The document provides a reference list of 30 sources on topics related to breast cancer pathology and classification. The references cover journal articles, books, websites, and other literature. They address issues such as the WHO classification of breast tumors, ductal carcinoma in situ, hormone receptor status, HER2 testing, squamous cell carcinoma of the breast, and methodologies for clinical research. The list cites international pathology and oncology publications from multiple decades ranging from the early 1990s to 2009.
The document provides a reference list of 30 sources on topics related to breast cancer pathology and classification. The references cover journal articles, books, websites, and other literature. They address issues such as the WHO classification of breast tumors, ductal carcinoma in situ, hormone receptor status, HER2 testing, squamous cell carcinoma of the breast, and methodologies for clinical research. The list cites international pathology and oncology publications from multiple decades ranging from the early 1990s to 2009.
1. Tavasolli, Devilee R. Pathology and Genetic of Tumours of the Breast and
Female Genital Organs/ WHO Classification of Tumours. IARC Press. 2003: 34-6. 2. Berek. Jonathan S. Breast Cancer in Novaks Gynecology. thirteen edition. Lippincott Williams & Wilkins.2002: 1375-93. 3. Kanker Payudara.[cited: 2009/12/10/]. available from: http://www.fortunestar.co.id 4. Breast Cancer-Male. [cited: 2009/12/10].available from: http://www.cancer.net-Breast Cancer-Male 5. Patten Bradley M. Human Embriology.second edition. Mc.Graw-Hill.240-1 6. Kissane. John M. Andersons Pathology. volume II. 9th edition. Mosby.1990: 1726-48 7. Juan Rosai. Ackermans Surgical Pathology. volume I. 9th edition. Mosby. 2004: 52-3. 2098-9. 8. Sjamsuhidajat R. de Jong. Buku Ajar Ilmu Bedah. EGC. 2000: 534-5 9. Tan, P.H.2001. Pathology of Ductal Carcinoma in Situ of The Breast: A Heterogeneous of Greater Understanding. Ann Acad Med Singapore. 30: 672-6. 10. Cotton, RE. Lecture Notes on Pathology. fourth edition. Blackwell Scientific publications. 1992: 53-5. 11. Mills Stacey et all. Stenbergs Diagnostic Surgical Pathology. volume IIB. 4th edition. Lippincott Williams & Wilkins. 2004: 332-3 12. Kumar. Abbas. Robbins and Cotran Pathologic Basis of Disease. 7th edition. Elsevier. 2005: 96. 296. 1119-51. 13. Robbins et all. Basic Pathology. 7th edition. Saunders. 2003: 705-17. 14. Anderdon. Famale Reproductive System. Volume 6. Churchill Livingstone. 1991: 208. 212. 215-218 15. Breast Cancer Genes and Inheritance. [cited : 2009/12/10] available from: http://familycancer.org/FamHist.5tm 16. Tapia C., Savic S., Wagner. 2007. Her2 Gene Status in Primary Breast Cancer and Matched Distant Metastasis. Breast Cancer Research. 17. Scheuner Maren T. Hereditary Breast Cancer. in Management of Breast Disease. Cedar-Sinai Medical Center.2007 18. Crum. C.P. Diagnostic Gynecologic and and Obstetric Pathology. Elsevier. 2006: 802-3. 19. Nadji mehrdad, Fernandez C., Gomez., Parvin. Immunohistochemistry of Estroge and Progesterone Receptors Reconsidered. AmJClinPathol.2005: 129: 21-27
52 Universitas Sumatera Utara
20. Moriki,T.,Tamotsu Takashi. Hormone Reseptor Status and HER2/neu
overexpression determined by automated imunostainer on routinely fixed cytologic specimens from breast carcinoma : Correlation with histologic sections determinations and Diagnostic Pitfalls, Abstract, Diagnostic Cytopathology.2006: 30(4): 251-6 21. Research Advocacy Network and NCCN. HER2 Testing: Summary for Breast Cancer Patients, Based on the NCCN Task Force Report:HER2 Testing in Breast Cancer.2006. 22. Chandrasoma et all, 2001. Concise Pathology. 3rd edition. McGraw-Hill International Edition. 742-55 23. Rubin,et all. Pathology.third edition. volume II. Lippincott Williams & Wilkins.2003: 1039-46 24. Rosen, P.Peter. Breast Pathology. Volume I. Second edition. Lippincott. Philadelphia.2001: 236-56 25. King, Bonnie L, Susan M, Love, et all. The fourth International Symposium on the Intraductal Approach to Breast Cancer. Santa Barbara. California. Breast Cancer Research. 2005.7.198-204 26. Breast Cancer.[cited: 2009/12/10]. Available from: http://www.meded.virginia.edu/Courses/path/gyn/breast 27. Nozoe T, Mori E, Ninomiya M, Maeda T, Matsukuma A, Nakashima H, Ezaki T. Squamous Cell Carcinoma of the Breast. The Japanese Breast Cancer Society 2009; DOI : 10.1007/s12282-009-1=0146-4. 28. Protocol Applied to All Invasion carcinoma of the Breast.[cited: 2009/12/10] Available from : www.cap.org/apps/docs/commitees/cancer/cancer protocols/2005/breast05 ckw.pdf 29. Okada K,Makihara K. A Case of Primary Squamous Cell carcinoma of the Breast with Rapid progression. Breast Cancer 2000:Vol.7 No.2 30. Sudigdo S.,Sofyan I.Dasar-Dasar Metodologi Penelitian Klinis. Jakarta.ISBN.2008
Edwin R. Fisher (Auth.), Prof. Dr. J. Zander, Prof. Dr. J. Baltzer (Eds.) - Early Breast Cancer - Histopathology, Diagnosis and Treatment-Springer-Verlag Berlin Heidelberg (1985) PDF